Pre-Clinical Trial Using Fresh Tumor Directly From Patients

  • LIDE provides pre-clinical assays using fresh clinical tumor samples directly from patients. FFPE prepared from tumor tissue can be subjected to either IHC assay or IMC analysis (Learn More) to determine indicated protein bio-markers, while single cell suspension generated from such tumor can be used to do FACS assay, K-cell RNA/DNA sequencing followed with FGI analysis (Learn More), or perform MiniPDX assay (Learn More) to find potential indication(s) specific to the treatment.

Pre-Clinical Trial Using Fresh Tumor Directly From Patients